Gene · 7030
Papers3,398
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 3,398
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Relevance of the Virchow Node and Virchow Triad in Renal Cancer Diagnosis. | Clin Pract | 2025 | 39851801 | PubTator, text mining | PubMed |
| GPNMB expression differentiates subependymal giant cell astrocytoma from other mimickers. | Ann Diagn Pathol | 2025 | 39837150 | PubTator, text mining | PubMed |
| TFE3-rearranged perivascular epithelioid cell tumors of the head and neck with rare fusion partners: clues to the differential diagnosis between benign and malignant tumors. | Diagn Pathol | 2025 | 39815310 | PubTator, text mining | PubMed |
| An autopsy case of TFE3-rearranged PEComa-like neoplasm with systematic embolization involving the heart. | Cardiovasc Pathol | 2025 | 39793912 | PubTator, text mining | PubMed |
| [MED15-TFE3 renal cell carcinoma: a clinicopathological and molecular analysis]. | Zhonghua Bing Li Xue Za Zhi | 2025 | 39762166 | PubTator, text mining | PubMed |
| TFE3-mediated neuroprotection: Clearance of aggregated α-synuclein and accumulated mitochondria in the AAV-α-synuclein model of Parkinson's disease. | Genes Dis | 2025 | 39759118 | PubTator, text mining | PubMed |
| The proximity-based protein interactome and regulatory logics of the transcription factor p65 NF-κB/RELA. | EMBO Rep | 2025 | 39753783 | PubTator, text mining | PubMed |
| YAP1::TFE3 fusion in a case of malignant TFE3-rearranged PEComa of the lung: expanding the spectrum of pulmonary PEComa-like mesenchymal neoplasms. | Virchows Arch | 2025 | 39751663 | PubTator, text mining | PubMed |
| The molecular code of kidney cancer: A path of discovery for gene mutation and precision therapy. | Mol Aspects Med | 2025 | 39746268 | PubTator, text mining | PubMed |
| The cGAS-STING pathway activates transcription factor TFEB to stimulate lysosome biogenesis and pathogen clearance. | Immunity | 2025 | 39689715 | PubTator, text mining | PubMed |
| TFE3 -rearranged Head and Neck Neoplasms : Twenty-two Cases Spanning the Morphologic Continuum Between Alveolar Soft Part Sarcoma and PEComa and Highlighting Genotypic Diversity. | Am J Surg Pathol | 2025 | 39593216 | PubTator, text mining | PubMed |
| Papillary renal cell carcinoma revisited: impact of the World Health Organization 2022 classification on prognostication. | BJU Int | 2025 | 39587415 | PubTator, text mining | PubMed |
| A Rare Case of an Infant With TFE3 Mutation Presenting With Direct Hyperbilirubinemia and Hepatomegaly. | Pediatr Dev Pathol | 2025 | 39584589 | PubTator, text mining | PubMed |
| Clinical, Histopathological, and Immunophenotypic Spectrum of Hepatic Epithelioid Hemangioendothelioma: Eight Years' Data of a Tertiary Care Center from North India. | J Clin Exp Hepatol | 2025 | 39564429 | PubTator, text mining | PubMed |
| Clear Cell Adenocarcinoma of the Urinary Tract Primary to the Renal Pelvis: A Multi-institutional Clinicopathologic and Molecular Study of Five Patients. | Am J Surg Pathol | 2025 | 39450999 | PubTator, text mining | PubMed |
| Clear Cell Stromal Tumor of the Lung: Clinicopathologic, Immunohistochemical, and Molecular Characterization of Eight Cases. | Mod Pathol | 2025 | 39424226 | PubTator, text mining | PubMed |
| TFE3 -Rearranged PEComa-like Neoplasm of the Kidney : A Case Report and Letter to the Editor. | Am J Surg Pathol | 2025 | 39371039 | PubTator, text mining | PubMed |
| Inflammatory spindle cell PEComa of the lung with YAP1::TFE3 fusion: a report of two cases and a potential relationship with clear cell stromal tumour. | Histopathology | 2025 | 39327855 | PubTator, text mining | PubMed |
| PHF1::TFE3-positive fibromyxoid sarcoma? Report of 2 cases and review of 13 cases of PHF1::TFE3-positive ossifying fibromyxoid tumor in the literature. | Am J Clin Pathol | 2025 | 39250713 | PubTator, text mining | PubMed |
| Genotype Phenotype Correlation of Renal Tumors in the Cancer Genome Atlas Database. | Int J Surg Pathol | 2025 | 39034146 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7030/papers?page=15